7don MSN
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Marty Makary wouldn't commit to maintaining current access to mifepristone during his Senate confirmation hearing on Thursday ...
Makaray says he will review data on mifepristone and follow the research where it leads him, with no preconceived ideas about ...
The U.S. Food and Drug Administration’s (FDA’s) reckless removal of safety protocols from the “mifepristone + misoprostol” abortion drug regimen is the latest move in a long line of ...
FDA approval, and medication availability; and not necessarily guided by evidence-based practice. For example, some obstetric providers choose to use misoprostol off-label because it is stable at ...
If confirmed as FDA commissioner, Makary will report to ... in which someone ends their pregnancy by taking two pills – mifepristone and misoprostol – rather than having a surgical procedure.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results